Skip to main content Skip to page footer

Cervical cancer

Logo des NCT Heidelberg Logo des NCT Heidelberg
Suche
×
 

Cervical cancer

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

There are currently no studies available

Metastatic Disease: First-Line-Therapy

There are currently no studies available

Metastatic Disease: Follow-Up Treatment

Title: A Phase 1B/2 Pan-Tumor, Open-Label Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)
Phase: II
Contact: Beatrice Stranz / Kontaktperson
Email-Address: Beatrice.Stranz(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Georg Martin Haag
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT06330064
EU CTIS/EudraCT: Die Studie ist im EU-CTIS registriert. CTIS: 2023-509632-26-00

Surgical Study

There are currently no studies available

Radiotherapy Study

Title: Daily AI-based Treatment Adaptation Under Weekly Offline MR-guidance in Chemoradiotherapy for Cervical Cancer 1 AIM-C1
Phase: II
Contact: Studienambulanz Strahlentherapie / Kontaktperson
Email-Address: studien.radonk(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Juliane Hörner-Rieber
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT06142760
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A:

Other study

Title: Beurteilung gynäkologischer Beckentumoren mittels MRT
Phase: N/A
Contact: Studienzimmer E010, Radiologie, dkfz / Kontaktperson
Email-Address: studien-radiologie(at)dkfz-heidelberg.de
Clinical Investigator: Dr. med. Theresa Mokry
Registration: Keine Registernummer angegeben.
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A: